PL372224A1 - Preparat rybawiryny w syropie - Google Patents

Preparat rybawiryny w syropie

Info

Publication number: PL372224A1
Authority: PL; Poland
Prior art keywords: ribavirin; syrup formulations; syrup; formulations; ribavirin syrup
Prior art date: 2001-10-31

Application number

PL02372224A

Other languages

English (en)

Other versions

PL205342B1 (pl

Inventor

Susan K. Heimbecher

Joel A. Sequeira

Original Assignee

Schering Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-31

Filing date

2002-10-31

Publication date

2005-07-11

2002-10-31 Application filed by Schering Corporation filed Critical Schering Corporation

2005-07-11 Publication of PL372224A1 publication Critical patent/PL372224A1/pl

2010-04-30 Publication of PL205342B1 publication Critical patent/PL205342B1/pl

Links

IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960000329 ribavirin Drugs 0.000 title 1
HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title 1
239000006188 syrup Substances 0.000 title 1
235000020357 syrup Nutrition 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL372224A 2001-10-31 2002-10-31 Ciekły preparat zawierający rybawirynę PL205342B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33475101P	2001-10-31	2001-10-31

Publications (2)

Publication Number	Publication Date
PL372224A1 true PL372224A1 (pl)	2005-07-11
PL205342B1 PL205342B1 (pl)	2010-04-30

Family

ID=23308655

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL372224A PL205342B1 (pl)	2001-10-31	2002-10-31	Ciekły preparat zawierający rybawirynę

Country Status (26)

Country	Link
US (1)	US6790837B2 (pl)
EP (1)	EP1480653B1 (pl)
JP (1)	JP4393192B2 (pl)
KR (1)	KR100929320B1 (pl)
CN (1)	CN1319535C (pl)
AR (1)	AR037131A1 (pl)
AT (1)	ATE439847T1 (pl)
AU (1)	AU2002350081B2 (pl)
BR (1)	BR0213536A (pl)
CA (1)	CA2464151C (pl)
CO (1)	CO5570681A2 (pl)
CY (1)	CY1110524T1 (pl)
DE (1)	DE60233438D1 (pl)
DK (1)	DK1480653T3 (pl)
ES (1)	ES2330419T3 (pl)
HU (1)	HU229259B1 (pl)
MX (1)	MXPA04004068A (pl)
NO (1)	NO334361B1 (pl)
NZ (1)	NZ531967A (pl)
PE (1)	PE20030545A1 (pl)
PL (1)	PL205342B1 (pl)
PT (1)	PT1480653E (pl)
SI (1)	SI1480653T1 (pl)
TW (1)	TWI259082B (pl)
WO (1)	WO2003037312A2 (pl)
ZA (1)	ZA200402975B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1867359B (zh) *	2003-10-08	2010-12-15	马林克罗特公司	哌甲酯溶液及其制药用途和制备方法
US20060110479A1 (en) *	2004-11-24	2006-05-25	Mitra Shankar K	Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
NZ582443A (en) *	2007-07-12	2011-04-29	Novartis Ag	Oral pharmaceutical solutions containing telbivudine
US8492386B2 (en)	2011-10-21	2013-07-23	Abbvie Inc.	Methods for treating HCV
EP2583677A3 (en)	2011-10-21	2013-07-03	Abbvie Inc.	Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon.
US8466159B2 (en)	2011-10-21	2013-06-18	Abbvie Inc.	Methods for treating HCV
DE202012012955U1 (de)	2011-10-21	2014-07-14	Abbvie Inc.	Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV
WO2013149258A2 (en)	2012-03-30	2013-10-03	Charles Drew University of Medicine and Science	Compositions and methods for treating or preventing metabolic syndrome disorders
US20140271923A1 (en)	2013-03-14	2014-09-18	Christopher Brian Reid	Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
EA201892448A1 (ru)	2016-04-28	2019-06-28	Эмори Юниверсити	Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
JP2018076280A (ja) *	2016-10-28	2018-05-17	国立大学法人大分大学	ジカウイルス感染症治療用医薬組成物
US20190336443A1 (en) *	2018-05-03	2019-11-07	Navinta Iii Inc	Ready-To-Use Liquid Parenteral Formulations Of Ribavirin
CN109568257A (zh) *	2018-12-24	2019-04-05	江西润泽药业有限公司	一种利巴韦林注射液及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4211771A (en)	1971-06-01	1980-07-08	Robins Ronald K	Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
JPS58198416A (ja) *	1982-05-15	1983-11-18	Ota Seiyaku Kk	セフアレキシンドライシロツプ剤の製造法
JPS63177797A (ja) *	1987-01-19	1988-07-21	Ajinomoto Co Inc	リボ−ス−１−リン酸及びリバビリンの製造法
US4880784A (en) *	1987-12-21	1989-11-14	Brigham Young University	Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
MX9605131A (es) *	1994-04-28	1997-10-31	Bionumerik Pharmaceutical Inc	Formulacion estable de lactona de 7-etil-camptotecina y metodo para usar la misma.
US5767097A (en) *	1996-01-23	1998-06-16	Icn Pharmaceuticals, Inc.	Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
US6423695B1 (en) *	1998-01-13	2002-07-23	Ribapharm, Inc.	Cytokine related treatments of disease
US6132758A (en) *	1998-06-01	2000-10-17	Schering Corporation	Stabilized antihistamine syrup

2002
- 2002-10-29 PE PE2002001063A patent/PE20030545A1/es not_active Application Discontinuation
- 2002-10-29 AR ARP020104108A patent/AR037131A1/es active IP Right Grant
- 2002-10-30 TW TW091132150A patent/TWI259082B/zh not_active IP Right Cessation
- 2002-10-31 EP EP02786612A patent/EP1480653B1/en not_active Expired - Lifetime
- 2002-10-31 JP JP2003539656A patent/JP4393192B2/ja not_active Expired - Fee Related
- 2002-10-31 CA CA2464151A patent/CA2464151C/en not_active Expired - Fee Related
- 2002-10-31 US US10/285,119 patent/US6790837B2/en not_active Expired - Lifetime
- 2002-10-31 DK DK02786612T patent/DK1480653T3/da active
- 2002-10-31 PT PT02786612T patent/PT1480653E/pt unknown
- 2002-10-31 PL PL372224A patent/PL205342B1/pl not_active IP Right Cessation
- 2002-10-31 AU AU2002350081A patent/AU2002350081B2/en not_active Ceased
- 2002-10-31 SI SI200230853T patent/SI1480653T1/sl unknown
- 2002-10-31 NZ NZ531967A patent/NZ531967A/en not_active IP Right Cessation
- 2002-10-31 MX MXPA04004068A patent/MXPA04004068A/es active IP Right Grant
- 2002-10-31 HU HU0600300A patent/HU229259B1/hu unknown
- 2002-10-31 AT AT02786612T patent/ATE439847T1/de active
- 2002-10-31 DE DE60233438T patent/DE60233438D1/de not_active Expired - Lifetime
- 2002-10-31 ES ES02786612T patent/ES2330419T3/es not_active Expired - Lifetime
- 2002-10-31 WO PCT/US2002/034898 patent/WO2003037312A2/en not_active Ceased
- 2002-10-31 KR KR1020047005865A patent/KR100929320B1/ko not_active Expired - Fee Related
- 2002-10-31 BR BR0213536-1A patent/BR0213536A/pt not_active IP Right Cessation
- 2002-10-31 CN CNB028217233A patent/CN1319535C/zh not_active Expired - Fee Related
2004
- 2004-04-19 ZA ZA2004/02975A patent/ZA200402975B/en unknown
- 2004-04-27 CO CO04038162A patent/CO5570681A2/es active IP Right Grant
- 2004-05-28 NO NO20042228A patent/NO334361B1/no not_active IP Right Cessation
2009
- 2009-10-29 CY CY20091101125T patent/CY1110524T1/el unknown

Also Published As

Publication number	Publication date
US6790837B2 (en)	2004-09-14
TW200300343A (en)	2003-06-01
NZ531967A (en)	2005-10-28
DK1480653T3 (da)	2009-11-30
CN1319535C (zh)	2007-06-06
HUP0600300A2 (en)	2006-07-28
CN1582155A (zh)	2005-02-16
ATE439847T1 (de)	2009-09-15
NO334361B1 (no)	2014-02-17
JP4393192B2 (ja)	2010-01-06
ZA200402975B (en)	2005-06-29
PE20030545A1 (es)	2003-06-19
WO2003037312A2 (en)	2003-05-08
NO20042228L (no)	2004-05-28
AR037131A1 (es)	2004-10-20
WO2003037312A3 (en)	2004-09-23
DE60233438D1 (de)	2009-10-01
EP1480653B1 (en)	2009-08-19
ES2330419T3 (es)	2009-12-10
HU229259B1 (en)	2013-10-28
EP1480653A2 (en)	2004-12-01
BR0213536A (pt)	2004-10-19
AU2002350081B2 (en)	2005-09-22
PT1480653E (pt)	2009-10-20
MXPA04004068A (es)	2004-09-06
JP2005507931A (ja)	2005-03-24
CA2464151A1 (en)	2003-05-08
KR100929320B1 (ko)	2009-11-27
HK1066719A1 (en)	2005-04-01
CY1110524T1 (el)	2015-04-29
CO5570681A2 (es)	2005-10-31
TWI259082B (en)	2006-08-01
SI1480653T1 (sl)	2009-12-31
CA2464151C (en)	2010-09-14
US20030087844A1 (en)	2003-05-08
KR20040047938A (ko)	2004-06-05
PL205342B1 (pl)	2010-04-30

Legal Events

Date	Code	Title	Description
2015-12-31	LAPS	Decisions on the lapse of the protection rights	Effective date: 20141031

Publication	Publication Date	Title
CA91172S (en)	2000-12-29	Candy
GB0126158D0 (en)	2002-01-02	Thin autotensioner
DE60234426D1 (en)	2009-12-31	Multiplexer
TW580228U (en)	2004-03-11	Carrying structure
DE60228850D1 (en)	2008-10-23	Thermoplastisches transparentes acrylnitril-butadien-styrol-harz (abs-harz)
HUP0600300A2 (en)	2006-07-28	Ribavirin syrup formulations
GB2372631B (en)	2005-08-03	Semiconductor-on-insulator structure
AU150240S (en)	2003-01-07	Lollipop
AU148337S (en)	2002-07-01	Candy
GB2383612B (en)	2003-12-03	Propulsion device
GB0125492D0 (en)	2001-12-12	Formulation
AU148338S (en)	2002-07-01	Candy
GB0106567D0 (en)	2001-05-09	Mutuagenesis Technique
GB0115893D0 (en)	2001-08-22	Formulations
GB2396812B (en)	2005-11-02	Formulation
GB2375048B (en)	2003-11-19	Formulation
GB0116619D0 (en)	2001-08-29	Formulation
AU143532S (en)	2001-04-10	Confectionery
TW493677U (en)	2002-07-01	Doorstopper structure
GB0112497D0 (en)	2001-07-11	Formulation
GB0508653D0 (en)	2005-06-08	Thin autotensioner
AP2001000099A0 (en)	2001-09-30	Sweet
AP2001000099S (en)	2005-08-27	Sweet
GB0128127D0 (en)	2002-01-16	Voucher
GB0107226D0 (en)	2001-05-16	Formulations